A detailed history of Aigen Investment Management, LP transactions in Liquidia Corp stock. As of the latest transaction made, Aigen Investment Management, LP holds 13,290 shares of LQDA stock, worth $146,322. This represents 0.03% of its overall portfolio holdings.

Number of Shares
13,290
Holding current value
$146,322
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$11.96 - $15.71 $158,948 - $208,785
13,290 New
13,290 $159,000
Q3 2023

Nov 13, 2023

BUY
$6.27 - $8.15 $79,127 - $102,853
12,620 New
12,620 $80,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.